Dalle Carbonare, L., et al. “Evidences of Safety and Tolerability of the Zoledronic Acid 5 Mg Yearly in the Post-Menopausal Osteoporosis: The HORIZON Project”. Reumatismo, vol. 61, no. 1, Mar. 2009, pp. 54-64, doi:10.4081/reumatismo.2009.54.